You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
OROXINE is indicated for the management of demonstrated thyroid hormone deficiency.,OROXINE is also used to suppress thyrotropin (TSH) for the management of TSH-responsive tumours of the thyroid.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
OROXINE is indicated for the management of demonstrated thyroid hormone deficiency.,OROXINE is also used to suppress thyrotropin (TSH) for the management of TSH-responsive tumours of the thyroid.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
OROXINE is indicated for the management of demonstrated thyroid hormone deficiency.,OROXINE is also used to suppress thyrotropin (TSH) for the management of TSH-responsive tumours of the thyroid.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
EUTROXSIG is indicated for the management of demonstrated thyroid hormone deficiency. EUTROXSIG is also used to suppress thyrotropin (TSH) for the management of TSH-responsive tumours of the thyroid. EUTROXSIG has also been used in the management of thyroiditis such as Hashimotos disease.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
OROXINE is indicated for the management of demonstrated thyroid hormone deficiency.,OROXINE is also used to suppress thyrotropin (TSH) for the management of TSH-responsive tumours of the thyroid.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Indicated for the management of demonstrated thyroid hormone deficiency. EUTROXSIG is also used to suppress thyrotropin (TSH) for the management of TSH-responsive tumours of the thyroid. EUTROXSIG has also been used in the management of thyroiditis such as Hashimotos disease.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
For the management of demonstrated thyoid hormone deficiency. EUTROXSIG is also used to suppress thyrotropin (TSH) for the management of TSH-responsive tumours of the thyroid. EUTROXSIG has also been used in the management of thyroiditis such as Hashimotos disease.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
For the management of demonstrated thyoid hormone deficiency. EUTROXSIG is also used to suppress thyrotropin (TSH) for the management of TSH-responsive tumours of the thyroid. EUTROXSIG has also been used in the management of thyroiditis such as Hashimotos disease.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.